# Efficacy and Safety of Micra AV2 Transcatheter Pacing System

Study · id `cardio:ct-nct07356505` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07356505](<https://clinicaltrials.gov/study/NCT07356505>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07356505

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT07356505. Allocation not applicable; no masking; primary purpose treatment. Start 2026-01-12 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT07356505, source copy `cardio:ctgov-nct07356505-2026-01-21`, retrieved 2026-10-26)
- Started: 2026-01-12 (actual) (ClinicalTrials.gov record NCT07356505, source copy `cardio:ctgov-nct07356505-2026-01-21`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT07356505, source copy `cardio:ctgov-nct07356505-2026-01-21`, retrieved 2026-10-26)
- Completion: 2029-01-31 (anticipated) (ClinicalTrials.gov record NCT07356505, source copy `cardio:ctgov-nct07356505-2026-01-21`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT07356505, source copy `cardio:ctgov-nct07356505-2026-01-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07356505-2026-01-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Micra AV2 Transcatheter Pacing System
- Acronym: EMAV2
- Condition: AV Block Complete
- Condition: AV Block-2Nd Degree-Type 1
- Condition: AV Block
- Intervention (Device): Implant procedure of a Micra AV2 leadless pacemaker (Medtronic)
- Lead sponsor: Universitaire Ziekenhuizen KU Leuven
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart block (`cardio:heart-block`)
- Registry lists this organization as the lead sponsor: Universitaire Ziekenhuizen KU Leuven (`cardio:org-universitaire-ziekenhuizen-ku-leuven`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: 0b6c4597501f4bde1a29662690aa32cde329f93e081d6d3ba3a2c150ae1c69d6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
